These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25437864)

  • 1. Identification of tumor endothelial cells with high aldehyde dehydrogenase activity and a highly angiogenic phenotype.
    Ohmura-Kakutani H; Akiyama K; Maishi N; Ohga N; Hida Y; Kawamoto T; Iida J; Shindoh M; Tsuchiya K; Shinohara N; Hida K
    PLoS One; 2014; 9(12):e113910. PubMed ID: 25437864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated tumor endothelial cells maintain specific character during long-term culture.
    Matsuda K; Ohga N; Hida Y; Muraki C; Tsuchiya K; Kurosu T; Akino T; Shih SC; Totsuka Y; Klagsbrun M; Shindoh M; Hida K
    Biochem Biophys Res Commun; 2010 Apr; 394(4):947-54. PubMed ID: 20302845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
    Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
    Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors.
    Ohga N; Ishikawa S; Maishi N; Akiyama K; Hida Y; Kawamoto T; Sadamoto Y; Osawa T; Yamamoto K; Kondoh M; Ohmura H; Shinohara N; Nonomura K; Shindoh M; Hida K
    Am J Pathol; 2012 Mar; 180(3):1294-1307. PubMed ID: 22245217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour endothelial cells acquire drug resistance in a tumour microenvironment.
    Hida K; Akiyama K; Ohga N; Maishi N; Hida Y
    J Biochem; 2013 Mar; 153(3):243-9. PubMed ID: 23293323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells.
    Xiong YQ; Sun HC; Zhang W; Zhu XD; Zhuang PY; Zhang JB; Wang L; Wu WZ; Qin LX; Tang ZY
    Clin Cancer Res; 2009 Aug; 15(15):4838-46. PubMed ID: 19638466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.
    Muraki C; Ohga N; Hida Y; Nishihara H; Kato Y; Tsuchiya K; Matsuda K; Totsuka Y; Shindoh M; Hida K
    Int J Cancer; 2012 Jan; 130(1):59-70. PubMed ID: 21384343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.
    Akiyama K; Ohga N; Maishi N; Hida Y; Kitayama K; Kawamoto T; Osawa T; Suzuki Y; Shinohara N; Nonomura K; Shindoh M; Hida K
    Pathol Int; 2013 Jan; 63(1):37-44. PubMed ID: 23356224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis.
    Osawa T; Ohga N; Akiyama K; Hida Y; Kitayama K; Kawamoto T; Yamamoto K; Maishi N; Kondoh M; Onodera Y; Fujie M; Shinohara N; Nonomura K; Shindoh M; Hida K
    Br J Cancer; 2013 Oct; 109(8):2237-47. PubMed ID: 24045659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR7: a novel tumor endothelial marker in renal cell carcinoma.
    Maishi N; Ohga N; Hida Y; Akiyama K; Kitayama K; Osawa T; Onodera Y; Shinohara N; Nonomura K; Shindoh M; Hida K
    Pathol Int; 2012 May; 62(5):309-17. PubMed ID: 22524658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.
    Kurosu T; Ohga N; Hida Y; Maishi N; Akiyama K; Kakuguchi W; Kuroshima T; Kondo M; Akino T; Totsuka Y; Shindoh M; Higashino F; Hida K
    Br J Cancer; 2011 Mar; 104(5):819-29. PubMed ID: 21285980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
    Al-Hilal TA; Chung SW; Choi JU; Alam F; Park J; Kim SW; Kim SY; Ahsan F; Kim IS; Byun Y
    J Clin Invest; 2016 Apr; 126(4):1251-66. PubMed ID: 26950422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual targeting of tumor and endothelial cells by gonadotropin-releasing hormone agonists to reduce melanoma angiogenesis.
    Moretti RM; Mai S; Montagnani Marelli M; Bani MR; Ghilardi C; Giavazzi R; Taylor DM; Martini PG; Limonta P
    Endocrinology; 2010 Oct; 151(10):4643-53. PubMed ID: 20685877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
    Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
    J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance.
    Hida K; Maishi N; Akiyama K; Ohmura-Kakutani H; Torii C; Ohga N; Osawa T; Kikuchi H; Morimoto H; Morimoto M; Shindoh M; Shinohara N; Hida Y
    Cancer Sci; 2017 Nov; 108(11):2195-2203. PubMed ID: 28851003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
    Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin αvβ5-induced secretion of VEGF-A.
    Desch A; Strozyk EA; Bauer AT; Huck V; Niemeyer V; Wieland T; Schneider SW
    Am J Pathol; 2012 Aug; 181(2):693-705. PubMed ID: 22659470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
    Claffey KP; Brown LF; del Aguila LF; Tognazzi K; Yeo KT; Manseau EJ; Dvorak HF
    Cancer Res; 1996 Jan; 56(1):172-81. PubMed ID: 8548760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.
    Akiyama K; Maishi N; Ohga N; Hida Y; Ohba Y; Alam MT; Kawamoto T; Ohmura H; Yamada K; Torii C; Shindoh M; Hida K
    Am J Pathol; 2015 Feb; 185(2):572-80. PubMed ID: 25498238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism.
    Li W; Shen S; Wu S; Chen Z; Hu C; Yan R
    Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.